Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Humacyte, Inc. | Chief Operating Officer | Common Stock | 0 | $0 | $9.41 | May 31, 2024 | Direct |
Humacyte, Inc. | Chief Operating Officer | Stock Options (right to buy) | 87.8K | May 30, 2024 | Direct | ||
Humacyte, Inc. | Chief Operating Officer | Stock Options (right to buy) | 2.63K | Dec 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HUMA | Humacyte, Inc. | Dec 19, 2024 | 1 | $0 | 4 | Dec 20, 2024 | Chief Operating Officer |
HUMA | Humacyte, Inc. | May 30, 2024 | 8 | -$1.21M | 4 | Jun 3, 2024 | Chief Operating Officer |
HUMA | Humacyte, Inc. | Dec 8, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Chief Operating Officer |
HUMA | Humacyte, Inc. | May 24, 2023 | 6 | -$157 | 4 | May 26, 2023 | Chief Operating Officer |
HUMA | Humacyte, Inc. | Dec 12, 2022 | 2 | $7.55K | 4 | Dec 13, 2022 | Chief Operating Officer |
HUMA | Humacyte, Inc. | Dec 8, 2022 | 1 | $0 | 4 | Dec 12, 2022 | Chief Operating Officer |
HUMA | Humacyte, Inc. | Aug 26, 2021 | 6 | $0 | 4 | Aug 27, 2021 | Chief Operating Officer |
HUMA | Humacyte, Inc. | Aug 26, 2021 | 0 | $0 | 3 | Aug 27, 2021 | Chief Operating Officer |